9 Meters Biopharma Inc. [NASDAQ:NMTR]’s prices stumbled on Friday.
Other data for the company is as follows:
- Stochastic %K of 75.21
- Weighted Alpha of null
The Bears are coming
Holding a Market Cap of $115.56 million, 9 Meters Biopharma Inc. has seen a trading range over the last year of $0.37-$1.22.
For the last five days, NMTR is down from its last closing price. The average shares trading hands each day is 6.52M, with average 10-day volume coming in at 2.07 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for NMTR. When we apply the Elder Force Index to 9 Meters Biopharma Inc., we are seeing an Elder Force Indicator number of -5918.5.
Recent Performance
The company’s enterprise value has gone from $79.71M to $19.43M quarter-over-quarter. Obviously, the company is heading in the wrong direction, but there are still opportunities for growth in the sector.
In the last quarter, NMTR made a profit of 1.02 million. In addition, the company has operating cash flow of -$16.04 million.
Technical Analysis
Looking at popular technical indicators, the company’s 5-day moving average is 0.8177 compared to the 50-day moving average of 0.7035. So, we are clearly seeing an upward trajectory here.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. NMTR currently holds a 9-day RSI of 64.06%, while 100-day RSI stands at 54.94%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. NMTR’s 9-day MACD is -0.0037 and the company’s 100-day MACD stands at 0.2029.
Inside Moves
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 10.24% by insiders and 2.73% by institutions.
Over the last six months, insiders have bought 21,485 with the most recent transaction from Sirgo Mark A, Director, with a purchase at price 0.65 per share.
Conclusion
Overall, the recommended rating for NMTR is Strong Buy. Currently, the company has 0 analysts watching the stock, and the average quarterly earnings estimate is 0.
